These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16175565)

  • 1. Impact of depressive symptoms on the treatment of generalized social anxiety disorder.
    Ledley DR; Huppert JD; Foa EB; Davidson JR; Keefe FJ; Potts NL
    Depress Anxiety; 2005; 22(4):161-7. PubMed ID: 16175565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
    Silverstone PH; Salinas E
    J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.
    Riggs PD; Mikulich-Gilbertson SK; Davies RD; Lohman M; Klein C; Stover SK
    Arch Pediatr Adolesc Med; 2007 Nov; 161(11):1026-34. PubMed ID: 17984403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial.
    Misri S; Reebye P; Corral M; Milis L
    J Clin Psychiatry; 2004 Sep; 65(9):1236-41. PubMed ID: 15367052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
    Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
    Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
    Sonawalla SB; Spillmann MK; Kolsky AR; Alpert JE; Nierenberg AA; Rosenbaum JF; Fava M
    J Clin Psychiatry; 1999 Sep; 60(9):580-3. PubMed ID: 10520975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderating effect of comorbid anxiety disorders on treatment outcome in a randomized controlled psychotherapy trial in early-onset persistently depressed outpatients.
    Assmann N; Schramm E; Kriston L; Hautzinger M; Härter M; Schweiger U; Klein JP
    Depress Anxiety; 2018 Oct; 35(10):1001-1008. PubMed ID: 30199128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Care of depressed patients with anxiety symptoms.
    Nutt DJ
    J Clin Psychiatry; 1999; 60 Suppl 17():23-7; discussion 46-8. PubMed ID: 10446738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder.
    Liebowitz MR; Careri J; Blatt K; Draine A; Morita J; Moran M; Hanover R
    Depress Anxiety; 2017 Dec; 34(12):1164-1172. PubMed ID: 29166552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of comorbid major depressive disorder or bipolar disorder on cognitive behavioral therapy for social anxiety disorder.
    Fracalanza K; McCabe RE; Taylor VH; Antony MM
    J Affect Disord; 2014 Jun; 162():61-6. PubMed ID: 24767007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.
    Judd LL; Rapaport MH; Yonkers KA; Rush AJ; Frank E; Thase ME; Kupfer DJ; Plewes JM; Schettler PJ; Tollefson G
    Am J Psychiatry; 2004 Oct; 161(10):1864-71. PubMed ID: 15465984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapy.
    Bellino S; Zizza M; Rinaldi C; Bogetto F
    Can J Psychiatry; 2007 Nov; 52(11):718-25. PubMed ID: 18399039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual symptoms in depressed patients who respond acutely to fluoxetine.
    Nierenberg AA; Keefe BR; Leslie VC; Alpert JE; Pava JA; Worthington JJ; Rosenbaum JF; Fava M
    J Clin Psychiatry; 1999 Apr; 60(4):221-5. PubMed ID: 10221281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
    March J; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J;
    JAMA; 2004 Aug; 292(7):807-20. PubMed ID: 15315995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive therapy for depressed adults with comorbid social phobia.
    Smits JA; Minhajuddin A; Jarrett RB
    J Affect Disord; 2009 Apr; 114(1-3):271-8. PubMed ID: 18804285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
    Ninan PT; Rush AJ; Crits-Christoph P; Kornstein SG; Manber R; Thase ME; Trivedi MH; Rothbaum BO; Zajecka J; Borian FE; Keller MB
    J Clin Psychiatry; 2002 May; 63(5):434-41. PubMed ID: 12025827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do comorbid social and other anxiety disorders predict outcomes during and after cognitive therapy for depression?
    Vittengl JR; Clark LA; Smits JAJ; Thase ME; Jarrett RB
    J Affect Disord; 2019 Jan; 242():150-158. PubMed ID: 30176494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group schema therapy versus group cognitive behavioral therapy for patients with social anxiety disorder and comorbid avoidant personality disorder: A randomized controlled trial.
    Baljé AE; Greeven A; Deen M; van Giezen AE; Arntz A; Spinhoven P
    J Anxiety Disord; 2024 Jun; 104():102860. PubMed ID: 38714138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.